Literature DB >> 28493613

Subtle blood-brain barrier leakage rate and spatial extent: Considerations for dynamic contrast-enhanced MRI.

Harm J van de Haar1,2,3, Jacobus F A Jansen1,3, Cécile R L P N Jeukens1, Saartje Burgmans2,3, Mark A van Buchem4, Majon Muller5, Paul A M Hofman1,3, Frans R J Verhey2,3, Matthias J P van Osch4, Walter H Backes1,3.   

Abstract

PURPOSE: Dynamic contrast-enhanced (DCE) MRI can be used to measure blood-brain barrier (BBB) leakage. In neurodegenerative disorders such as small vessel disease and dementia, the leakage can be very subtle and the corresponding signal can be rather noisy. For these reasons, an optimized DCE-MRI measurement and study design is required. To this end, a new measure indicative of the spatial extent of leakage is introduced and the effects of scan time and sample size are explored.
METHODS: Dual-time resolution DCE-MRI was performed in 16 patients with early Alzheimer's disease (AD) and 17 healthy controls. The leakage rate (Ki ) and volume fraction of detectable leaking tissue (vL ) to quantify the spatial extent of BBB leakage were calculated in cortical gray matter and white matter using noise-corrected histogram analysis of leakage maps. Computer simulations utilizing realistic Ki histograms, mimicking the strong effect of noise and variation in Ki values, were performed to understand the influence of scan time on the estimated leakage.
RESULTS: The mean Ki was very low (order of 10-4 min-1 ) and highly influenced by noise, causing the Ki to be increasingly overestimated at shorter scan times. In the white matter, the Ki was not different between patients with early AD and controls, but was higher in the cortex for patients, reaching significance after 14.5 min of scan time. To detect group differences, vL proved more suitable, showing significantly higher values for patients compared with controls in the cortex after 8 minutes of scan time, and in white matter after 15.5 min.
CONCLUSIONS: Several ways to improve the sensitivity of a DCE-MRI experiment to subtle BBB leakage were presented. We have provided vL as an attractive and potentially more time-efficient alternative to detect group differences in subtle and widespread blood-brain barrier leakage compared with leakage rate Ki . Recommendations on group size and scan time are made based on statistical power calculations to aid future research.
© 2017 American Association of Physicists in Medicine.

Entities:  

Keywords:  Alzheimer's disease; blood-brain barrier; brain MRI; dynamic contrast-enhanced MRI, leakage; pharmacokinetic modeling

Mesh:

Substances:

Year:  2017        PMID: 28493613     DOI: 10.1002/mp.12328

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  29 in total

1.  Methodologic Concerns on the Reported Values for Assessing Permeability of the Blood-Brain Barrier in the Hippocampus.

Authors:  C M Lim; W-J Moon
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-28       Impact factor: 3.825

2.  Shedding Light on the Blood-Brain Barrier Transport with Two-Photon Microscopy In Vivo.

Authors:  Krzysztof Kucharz; Nikolay Kutuzov; Oleg Zhukov; Mette Mathiesen Janiurek; Martin Lauritzen
Journal:  Pharm Res       Date:  2022-05-16       Impact factor: 4.200

3.  An In Vitro Model of the Blood-Brain Barrier to Study Alzheimer's Disease: The Role of β-Amyloid and Its Influence on PBMC Infiltration.

Authors:  Simona Federica Spampinato; Yukio Takeshita; Birgit Obermeier
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Magnetic Resonance Imaging of Blood-Brain Barrier permeability in Dementia.

Authors:  Audrey Chagnot; Samuel R Barnes; Axel Montagne
Journal:  Neuroscience       Date:  2021-08-13       Impact factor: 3.708

Review 5.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 6.  The role of brain vasculature in neurodegenerative disorders.

Authors:  Melanie D Sweeney; Kassandra Kisler; Axel Montagne; Arthur W Toga; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

Review 7.  MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies.

Authors:  Rajikha Raja; Gary A Rosenberg; Arvind Caprihan
Journal:  Neuropharmacology       Date:  2017-10-28       Impact factor: 5.250

8.  Measurement of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging with reduced scan time.

Authors:  Jonghyun Bae; Jin Zhang; Youssef Zaim Wadghiri; Atul Singh Minhas; Harish Poptani; Yulin Ge; Sungheon Gene Kim
Journal:  Magn Reson Med       Date:  2018-03-05       Impact factor: 4.668

Review 9.  Methods used for the measurement of blood-brain barrier integrity.

Authors:  Huixin Sun; Huiling Hu; Chuanjie Liu; Nannan Sun; Chaohui Duan
Journal:  Metab Brain Dis       Date:  2021-02-26       Impact factor: 3.584

10.  Undetectable gadolinium brain retention in individuals with an age-dependent blood-brain barrier breakdown in the hippocampus and mild cognitive impairment.

Authors:  Axel Montagne; Mikko T Huuskonen; Gautham Rajagopal; Melanie D Sweeney; Daniel A Nation; Farshid Sepehrband; Lina M D'Orazio; Michael G Harrington; Helena C Chui; Meng Law; Arthur W Toga; Berislav V Zlokovic
Journal:  Alzheimers Dement       Date:  2019-12       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.